Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Discover how mRNA vaccines could revolutionize medicine by targeting 9 major diseases. Learn about breakthrough treatments ...

Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...

President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their ...

Contradictory COVID-19 policies and dismissal of scientific debate undermined trust in health institutions, contributing to ...

We’ve now seen a coronavirus epidemic every decade in ... who co-directs the Texas Children’s Hospital Center for Vaccine Development with Bottazzi, where they make protein vaccines for ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump administration vs. mRNA vaccines ...

CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.